Free Trial

Actuate Therapeutics (ACTU) Earnings Date, Estimates & Call Transcripts

Actuate Therapeutics logo
$9.30 +0.09 (+0.98%)
Closing price 05/7/2025 04:00 PM Eastern
Extended Trading
$9.32 +0.02 (+0.22%)
As of 05/7/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Actuate Therapeutics Earnings Summary

Actual EPS
(Sep. 24)
-$4.20 Missed By -$4.20

Actuate Therapeutics released Q2 2024 earnings on September 24, 2024, reporting an EPS of -$4.20. Actuate Therapeutics currently has a trailing EPS of $0.00

Q2 2024 Earnings Resources

Get Actuate Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Actuate Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ACTU Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Actuate Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.26-$0.26-$0.26
Q2 20251-$0.19-$0.19-$0.19
Q3 20251-$0.18-$0.18-$0.18
Q4 20251-$0.21-$0.21-$0.21

Actuate Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
9/24/2024Q2 2024--$4.20 -$4.20-$4.20--
7/23/2024Q1 2024--$5.40 -$5.40-$5.40--


This page (NASDAQ:ACTU) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners